7-Benzoyl-2,7-diazaspiro[3.5]nonane is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active compounds. Its unique spirocyclic structure makes it a valuable scaffold for developing potential drug candidates, particularly in the design of molecules targeting neurological disorders. Researchers have explored its application in creating inhibitors for enzymes involved in neurodegenerative diseases, such as monoamine oxidases, which play a role in the breakdown of neurotransmitters. Additionally, its benzoyl group provides a versatile site for further chemical modifications, enabling the development of compounds with enhanced binding affinity and selectivity. This chemical is also investigated for its potential use in the development of novel antipsychotic and antidepressant agents, owing to its ability to interact with specific receptors in the central nervous system. Its application extends to the study of receptor-ligand interactions, aiding in the understanding of complex biochemical pathways and the discovery of new therapeutic targets.